SIMS KAREN (Chief Medical Officer) received a stock award from ARBUTUS BIOPHARMA CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2025ACC: 0001447028-25-000049
Officer· Chief Medical Officer
Since Jul 2023
+249.60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
249.60K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+49.30K
Price / share
—
Trade value
—
% of position
46.4%
2/14/2025
106.19K→155.49K
Total
Net shares
+49.30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/14/2025 | A · Award | +49.30K | — | — | 46.4% | 106.19K | 155.49K |
| Total | +49.30K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
200.30K shares
Shares
+200.30K
Strike price
3.29
Held after
200.30K
Exercisable
—
2/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares200.30K shares | 2/14/2025 | A · Award | +200.30K | 3.29 | — | 200.30K |